Prospects for Control of Herpes Simplex Virus Disease through Immunization
Citations Over TimeTop 1% of 2000 papers
Abstract
Herpes simplex viruses (HSVs) can cause a variety of infections, including genital herpes. Despite effective antiviral therapy, HSV infections remain a significant worldwide public health problem. Vaccines offer the best hope for controlling spread and limiting HSV disease. This article discusses the pathogenesis and immunobiology of mucocutaneous HSV infections, summarizes the spectrum of diseases caused by HSV, and provides a review of the field of HSV vaccine research. This article also discusses what might be realistically expected of a vaccine intended for control of genital herpes and explores the question of whether a vaccine that is effective in controlling genital HSV disease might also be effective in controlling nongenital HSV disease. The efficacy of such vaccines for the full spectrum of HSV disease will eventually determine the timing and targeting of immunization, ranging from selective immunization in preadolescence to universal childhood immunization as part of the routine childhood regimen.
Related Papers
- Behçet's disease: treatment of mucocutaneous lesions.(2005)
- → Mucocutaneous manifestations of HIV‐infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China(2012)37 cited
- → Outcome of pemphigus vulgaris(2008)27 cited
- Peutz-Jeghers syndrome without mucocutaneous pigmentation: a case report.(2012)
- → 16880 Prevalence of mucocutaneous findings in an inception systemic lupus erythematosus cohort(2020)